Review
Open access
Sep 2026
mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety
Whether mRNA platforms offer incremental benefits over enhanced formulations (such as high-dose, adjuvanted, or recombinant vaccines), which are the preferred options in some countries for older adults, remains to be established.
A. Domnich, Andrea Orsi
· Frontiers in Immunology · 0 citations